{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T07:25:09Z","timestamp":1786951509345,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10735-026-10910-3","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:12:39Z","timestamp":1785384759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prophylactic administration of silica nanoparticles loaded with amifostine prevents cisplatin-induced nephrotoxicity in rats"],"prefix":"10.1007","volume":"57","author":[{"given":"Rehab A.","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawoud F.","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha E.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zakaria","family":"El-Khayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal M.","family":"El-Feky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enayat","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagdy K. B.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amani F. H.","family":"Noureldeen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"issue":"9","key":"10910_CR1","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.3390\/molecules29091927","volume":"29","author":"SA Abass","year":"2024","unstructured":"Abass SA, Elgazar AA, El-Kholy SS, El-Refaiy AI, Nawaya RA, Bhat MA, Farrag FA, Hamdi A, Balaha M, El-Magd MA (2024) Unraveling the nephroprotective potential of papaverine against cisplatin toxicity through mitigating oxidative stress and inflammation: insights from in silico, in vitro, and in vivo investigations. Molecules 29(9):1927","journal-title":"Molecules"},{"issue":"2","key":"10910_CR2","first-page":"399","volume":"31","author":"FG Apayd\u0131n","year":"2018","unstructured":"Apayd\u0131n FG, Kaltal\u0131o\u011flu K, Balabanl\u0131 B, Cevher \u015eC (2018) Morin and hesperidin ameliorate cisplatin-induced hepatotoxicity and nephrotoxicity in rats: A histopathological study. Gazi Univ J Sci 31(2):399\u2013406","journal-title":"Gazi Univ J Sci"},{"key":"10910_CR3","volume-title":"AVMA Guidelines for the Euthanasia of Animals: 2020 Edition","author":"AVMA","year":"2020","unstructured":"AVMA (2020) AVMA Guidelines for the Euthanasia of Animals: 2020 Edition. American Veterinary Medical Association, Schaumburg, IL"},{"issue":"12","key":"10910_CR4","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/biom13121743","volume":"13","author":"J Bharati","year":"2023","unstructured":"Bharati J, Kumar M, Kumar N, Malhotra A, Singhal PC (2023) MicroRNA193a: an emerging mediator of glomerular diseases. Biomolecules 13(12):1743","journal-title":"Biomolecules"},{"issue":"12","key":"10910_CR5","doi-asserted-by":"publisher","first-page":"e11353","DOI":"10.1590\/1414-431x2021e11353","volume":"54","author":"A Budu","year":"2021","unstructured":"Budu A, Freitas-Lima LC, Arruda AD, Perilh\u00e3o MS, Barrera-Chimal J, Ara\u00fajo RC, Estrela GR (2021) Renal fibrosis due to multiple cisplatin treatment is exacerbated by kinin B1 receptor antagonism. Braz J Med Biol Res 54(12):e11353","journal-title":"Braz J Med Biol Res"},{"key":"10910_CR6","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/S0959-8049(96)00333-4","volume":"32","author":"RL Capizzi","year":"1996","unstructured":"Capizzi RL (1996) The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (ethyol\u00ae). Eur J Cancer 32:S5\u201316","journal-title":"Eur J Cancer"},{"issue":"4","key":"10910_CR7","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/ijms18040776","volume":"18","author":"Z Cheng","year":"2017","unstructured":"Cheng Z, Limbu MH, Wang Z, Liu J, Liu L, Zhang X, Chen P, Liu B (2017) MMP-2 and 9 in chronic kidney disease. Int J Mol Sci 18(4):776","journal-title":"Int J Mol Sci"},{"key":"10910_CR8","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari S, Tchounwou PB (2014) Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol 740:364\u2013378","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10910_CR9","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s12951-022-01718-w","volume":"20","author":"M Davoudi","year":"2022","unstructured":"Davoudi M, Jadidi Y, Moayedi K, Farrokhi V, Afrisham R (2022) Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011\u20132022 review. J Nanobiotechnol 20(1):504","journal-title":"J Nanobiotechnol"},{"key":"10910_CR10","doi-asserted-by":"publisher","first-page":"106939","DOI":"10.1016\/j.ejps.2024.106939","volume":"203","author":"EA Elmorsy","year":"2024","unstructured":"Elmorsy EA, Saber S, Hamad RS, Abdel-Reheim MA, El-Kott AF, AlShehri MA, Morsy K, Salama SA, Youssef ME (2024) Advances in understanding cisplatin-induced toxicity: molecular mechanisms and protective strategies. Eur J Pharm Sci 203:106939","journal-title":"Eur J Pharm Sci"},{"issue":"23","key":"10910_CR11","doi-asserted-by":"publisher","first-page":"10212","DOI":"10.1021\/acs.iecr.4c00506","volume":"63","author":"M Ganguly","year":"2024","unstructured":"Ganguly M, Debraj D, Mazumder N, Carpenter J, Manickam S, Pandit AB (2024) Impact of Ultrasonication on the oxidative stability of oil-in-water Nanoemulsions: investigations into kinetics and strategies to control lipid oxidation. Ind Eng Chem Res 63(23):10212\u201310225","journal-title":"Ind Eng Chem Res"},{"issue":"9","key":"10910_CR12","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/biomedicines11092358","volume":"11","author":"A Gluba-Sagr","year":"2023","unstructured":"Gluba-Sagr A, Franczyk B, Rysz-G\u00f3rzy\u0144ska M, \u0141awi\u0144ski J, Rysz J (2023) The role of miRNA in renal fibrosis leading to chronic kidney disease. Biomedicines 11(9):2358","journal-title":"Biomedicines"},{"key":"10910_CR13","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1146\/annurev-physiol-020911-153238","volume":"74","author":"A Greka","year":"2012","unstructured":"Greka A, Mundel P (2012) Cell biology and pathology of podocytes. Annu Rev Physiol 74:299\u2013323","journal-title":"Annu Rev Physiol"},{"key":"10910_CR14","doi-asserted-by":"publisher","first-page":"1497026","DOI":"10.3389\/fimmu.2024.1497026","volume":"15","author":"S Guo","year":"2025","unstructured":"Guo S, Zhang Q, Guo Y, Yin X, Zhang P, Mao T, Tian Z, Li X (2025) The role and therapeutic targeting of the CCL2\/CCR2 signaling axis in inflammatory and fibrotic diseases. Front Immunol 15:1497026","journal-title":"Front Immunol"},{"issue":"7","key":"10910_CR15","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1021\/acs.jmedchem.5b01628","volume":"59","author":"M Hofer","year":"2016","unstructured":"Hofer M, Falk M, Kom\u016frkov\u00e1 D, Falkov\u00e1 I, Bacikova A, Klejdus B, Pagacova E, Stefancikova L, Weiterov\u00e1 L, Angelis KJ, Kozubek S (2016) Two new faces of amifostine: protector from DNA damage in normal cells and inhibitor of DNA repair in cancer cells. J Med Chem 59(7):3003\u20133017","journal-title":"J Med Chem"},{"key":"10910_CR16","doi-asserted-by":"publisher","first-page":"1610296","DOI":"10.3389\/fimmu.2025.1610296","volume":"16","author":"Y Huang","year":"2025","unstructured":"Huang Y, Lv X, Si T, Meng X, Liao X, Zhang P, Peng Z, Zhou Z, Yi P, Huang S (2025) Immuno-protective impact and clinical translation of radioprotective agents in cancer radiotherapy. Front Immunol 16:1610296","journal-title":"Front Immunol"},{"issue":"2","key":"10910_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1124\/jpet.108.139162","volume":"327","author":"M Jiang","year":"2008","unstructured":"Jiang M, Dong Z (2008) Regulation and pathological role of p53 in cisplatin nephrotoxicity. J Pharmacol Exp Ther 327(2):300\u2013307","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10910_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.toxlet.2015.06.012","volume":"237","author":"T Karasawa","year":"2015","unstructured":"Karasawa T, Steyger PS (2015) An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 237(3):219\u2013227","journal-title":"Toxicol Lett"},{"issue":"8","key":"10910_CR19","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland L (2007) The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer 7(8):573\u2013584","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10910_CR20","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","volume":"44","author":"AJ Kriegel","year":"2012","unstructured":"Kriegel AJ, Liu Y, Fang Y, Ding X, Liang M (2012) The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genom 44(4):237\u2013244","journal-title":"Physiol Genom"},{"issue":"5","key":"10910_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.31083\/j.fbl2905192","volume":"29","author":"A La Russa","year":"2024","unstructured":"La Russa A, Serra R, Faga T, Crugliano G, Bonelli A, Coppolino G, Bolignano D, Battaglia Y, Ielapi N, Costa D, Michael A (2024) Kidney fibrosis and matrix metalloproteinases (MMPs). Front Bioscience-Landmark 29(5):192","journal-title":"Front Bioscience-Landmark"},{"issue":"22","key":"10910_CR22","doi-asserted-by":"publisher","first-page":"12096","DOI":"10.3390\/ijms252212096","volume":"25","author":"MM Lee","year":"2024","unstructured":"Lee MM, Chou YX, Huang SH, Cheng HT, Liu CH, Huang GJ (2024) Renoprotective effects of brown-strain Flammulina velutipes Singer in chronic kidney disease-induced mice through modulation of oxidative stress and inflammation and regulation of renal transporters. Int J Mol Sci 25(22):12096","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10910_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3892\/mmr.2021.12094","volume":"23","author":"N Li","year":"2021","unstructured":"Li N, Chen J, Wang P, Fan H, Hou S, Gong Y (2021) Major signaling pathways and key mediators of macrophages in acute kidney injury. Mol Med Rep 23(6):455","journal-title":"Mol Med Rep"},{"issue":"37","key":"10910_CR24","doi-asserted-by":"publisher","first-page":"20241","DOI":"10.1021\/acs.jafc.4c05910","volume":"72","author":"Y Li","year":"2024","unstructured":"Li Y, Liu J, McClements DJ, Zhang X, Zhang T, Du Z (2024) Recent advances in Hollow nanostructures: synthesis methods, structural characteristics, and applications in Food and Biomedicine. J Agric Food Chem 72(37):20241\u201320260","journal-title":"J Agric Food Chem"},{"key":"10910_CR25","doi-asserted-by":"crossref","unstructured":"Liu Y, Liang Y, Yuhong J, Xin P, Han JL, Du Y, Yu X, Zhu R, Zhang M, Chen W, Ma Y (2024) Advances in nanotechnology for enhancing the solubility and bioavailability of poorly soluble drugs. Drug Design Dev Therapy 18:1469\u20131495","DOI":"10.2147\/DDDT.S447496"},{"issue":"2","key":"10910_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1515\/jcim-2024-0250","volume":"22","author":"MM Masoud","year":"2025","unstructured":"Masoud MM, El-Laithy NA, Youness ER, Ahmed NM, Mahdy EM, Shousha WG (2025) Effect of amifostine on apoptotic inflammatory makers in cisplatin induced brain damage in rats. J Complement Integr Med 22(2):279\u2013287","journal-title":"J Complement Integr Med"},{"issue":"2","key":"10910_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R (2021) Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discovery 20(2):101\u2013124","journal-title":"Nat Rev Drug Discovery"},{"key":"10910_CR28","unstructured":"Mohamed RA, Hamid FFA, Habib DF, Mohamed NA, Khalil WK, Ahmed EK, Noureldeen AF (2023) Protective potency of nano-emulsified amifostine against cisplatin induced nephrotoxicity in rats. Annals Biol 39(1):123\u2013129"},{"issue":"1","key":"10910_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-016-0553-2","volume":"14","author":"IJ Onakpoya","year":"2016","unstructured":"Onakpoya IJ, Heneghan CJ, Aronson JK (2016) Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature. BMC Med 14(1):10","journal-title":"BMC Med"},{"issue":"6","key":"10910_CR31","first-page":"550","volume":"25","author":"MA Perazella","year":"2019","unstructured":"Perazella MA (2019) Drug-induced acute kidney injury: diverse mechanisms of tubular injury. Curr Opin Crit Care 25(6):550\u2013557","journal-title":"Curr Opin Crit Care"},{"issue":"8","key":"10910_CR30","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2215\/CJN.11290821","volume":"17","author":"MA Perazella","year":"2022","unstructured":"Perazella MA, Rosner MH (2022) Drug-induced acute kidney injury. Clin J Am Soc Nephrol 17(8):1220\u20131233","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10910_CR32","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1681\/ASN.2010121308","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY (2011) TGF-\u03b2\/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22(8):1462\u20131474","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10910_CR33","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1080\/14728222.2020.1762173","volume":"24","author":"S Rayego-Mateos","year":"2020","unstructured":"Rayego-Mateos S, Valdivielso JM (2020) New therapeutic targets in chronic kidney disease progression and renal fibrosis. Expert Opin Ther Targets 24(7):655\u2013670","journal-title":"Expert Opin Ther Targets"},{"issue":"6","key":"10910_CR34","doi-asserted-by":"publisher","first-page":"e141669","DOI":"10.5812\/aapm-141669","volume":"13","author":"OM Rehab","year":"2023","unstructured":"Rehab OM, Bakr DM, Algazzar OA, Morsy I (2023) Effect of intravenous aminophylline on hemodynamics and recovery of patients undergoing functional endoscopic sinus surgery under dexmedetomidine hypotensive anesthesia: a randomized controlled study. Anesthesiology Pain Med 13(6):e141669","journal-title":"Anesthesiology Pain Med"},{"issue":"7","key":"10910_CR35","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.3390\/ijms25073678","volume":"25","author":"H Rupprecht","year":"2024","unstructured":"Rupprecht H, Catanese L, Amann K, Hengel FE, Huber TB, Latosinska A, Lindenmeyer MT, Mischak H, Siwy J, Wendt R, Beige J (2024) Assessment and risk prediction of chronic kidney disease and kidney fibrosis using non-invasive biomarkers. Int J Mol Sci 25(7):3678","journal-title":"Int J Mol Sci"},{"key":"10910_CR36","doi-asserted-by":"crossref","unstructured":"Talebi M, Talebi M, Farkhondeh T, Simal-Gandara J, \u0130lg\u00fcn S, Pourbagher-Shahri AM, Samini M, Samarghandian S (2024) A review on hepatoprotective effect of chrysin: preclinical implications and molecular cascades came into focus. Curr Diabetes Rev 22:e15733998329724","DOI":"10.2174\/0115733998329724240918091335"},{"issue":"1","key":"10910_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41581-022-00631-7","volume":"19","author":"C Tang","year":"2023","unstructured":"Tang C, Livingston MJ, Safirstein R, Dong Z (2023) Cisplatin nephrotoxicity: new insights and therapeutic implications. Nat Rev Nephrol 19(1):53\u201372","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10910_CR38","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1681\/ASN.2011010055","volume":"23","author":"B Wang","year":"2012","unstructured":"Wang B, Komers R, Carew R, Winbanks CE, Xu B, Herman-Edelstein M, Koh P, Thomas M, Jandeleit-Dahm K, Gregorevic P, Cooper ME (2012) Suppression of microRNA-29 expression by TGF-\u03b21 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 23(2):252\u2013265","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10910_CR39","doi-asserted-by":"publisher","first-page":"114238","DOI":"10.1016\/j.yexcr.2024.114238","volume":"442","author":"P Wang","year":"2024","unstructured":"Wang P, Yang J, Dai S, Gao P, Qi Y, Zhao X, Liu J, Wang Y, Gao Y (2024) miRNA-193a-mediated WT1 suppression triggers podocyte injury through activation of the EZH2\/\u03b2-catenin\/NLRP3 pathway in children with diabetic nephropathy. Exp Cell Res 442(2):114238","journal-title":"Exp Cell Res"},{"issue":"9","key":"10910_CR40","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018. JAMA 323(9):844\u2013853. https:\/\/doi.org\/10.1001\/jama.2020.1166","journal-title":"JAMA"},{"key":"10910_CR41","doi-asserted-by":"publisher","first-page":"1646412","DOI":"10.3389\/fmed.2025.1646412","volume":"12","author":"T Yuan","year":"2025","unstructured":"Yuan T, Wang H, Kang T, Wu W, Ou S (2025) Advancements in the non-invasive diagnosis of renal fibrosis. Front Med 12:1646412","journal-title":"Front Med"},{"issue":"1","key":"10910_CR42","first-page":"1612348","volume":"2022","author":"J Zhou","year":"2022","unstructured":"Zhou J, Nie RC, Yin YX, Cai XX, Xie D, Cai MY (2022) Protective effect of natural antioxidants on reducing Cisplatin-Induced nephrotoxicity. Dis Markers 2022(1):1612348","journal-title":"Dis Markers"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-10910-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-10910-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:49:05Z","timestamp":1786949345000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-026-10910-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10910"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-10910-3","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"17 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were conducted in accordance with national and international guidelines for the care and use of laboratory animals, including the ARRIVE Guidelines and the American Veterinary Medical Association (2020) recommendations. The study protocol was reviewed and approved by the Ethics Committee of the National Research Centre, Cairo, Egypt (Approval No. 17\/118). The authors further acknowledge that ether will not be employed in future investigations, and all anesthesia and euthanasia procedures will strictly adhere to updated international welfare standards.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"254"}}